The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

Parkinson’s disease is the second most common neurodegenerative disorder; it affects 1% of the population over the age of 65. The number of people with Parkinson’s disease is set to rapidly increase due to changing demographics and there is an unmet clinical need for disease-modifying therapies. The...

Full description

Bibliographic Details
Main Authors: Susan R Goulding, Aideen M Sullivan, Gerard W O'Keeffe, Louise M Collins
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
axon growth; bmp2; dopaminergic neurons; neuroprotection; neurotrophic factor; neuroregeneration; parkinson’s disease; α-synuclein
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=8;spage=1432;epage=1436;aulast=Goulding

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=8;spage=1432;epage=1436;aulast=Goulding

Similar Items